Insider · CIK 0001722140

Ceesay Abraham

CIK 0001722140 Name as filed on the most recent filing

Filed as Ceesay Abraham (15)

42 transaction lines · from 15 filings · filed 2022-08-09 to 2026-08-12 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

42 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-08-11 S, Open-market sale Rapport Therapeutics, Inc.RAPP 3 lines 1,390,405, disposed Open Form 4 filing 0001193125-26-346995
2026-08-10 S, Open-market sale Rapport Therapeutics, Inc.RAPP 2 lines 1,042,772, disposed Open Form 4 filing 0001193125-26-346995
2026-07-27 S, Open-market sale Rapport Therapeutics, Inc.RAPP 2 lines 93,061, disposed Open Form 4 filing 0001193125-26-323637
2026-07-14 S, Open-market sale Rapport Therapeutics, Inc.RAPP 2 lines 328,437, disposed Open Form 4 filing 0001193125-26-304786
2026-06-29 S, Open-market sale Rapport Therapeutics, Inc.RAPP 2 lines 327,398, disposed Open Form 4 filing 0001193125-26-292519
2026-02-18 S, Open-market sale Rapport Therapeutics, Inc.RAPP 4 lines 320,373, disposed Open Form 4 filing 0001193125-26-059886
2026-01-20 S, Open-market sale Rapport Therapeutics, Inc.RAPP 2 lines 285,071, disposed Open Form 4 filing 0001193125-26-019820
2025-12-17 S, Open-market sale Rapport Therapeutics, Inc.RAPP 6 lines 323,508, disposed Open Form 4 filing 0001193125-25-324826
2025-11-17 S, Open-market sale Rapport Therapeutics, Inc.RAPP 4 lines 275,047, disposed Open Form 4 filing 0001193125-25-286218
2025-10-15 S, Open-market sale Rapport Therapeutics, Inc.RAPP 4 lines 281,729, disposed Open Form 4 filing 0001193125-25-241472
2025-09-17 S, Open-market sale Rapport Therapeutics, Inc.RAPP 4 lines 2,011,197, disposed Open Form 4 filing 0001193125-25-209062
2025-09-04 S, Open-market sale Pacira BioSciences, Inc.PCRX 64,005, disposed Open Form 4 filing 0001396814-25-000109
2022-09-08 S, Open-market sale Cerevel Therapeutics Holdings, Inc.CERE 624,325, disposed Open Form 4 filing 0000899243-22-030798
2022-08-22 S, Open-market sale Cerevel Therapeutics Holdings, Inc.CERE 312,163, disposed Open Form 4 filing 0000899243-22-029606
2022-08-15 S, Open-market sale Cerevel Therapeutics Holdings, Inc.CERE 327,757, disposed Open Form 4 filing 0000899243-22-028978
2022-08-08 S, Open-market sale Cerevel Therapeutics Holdings, Inc.CERE 2 lines 742,024, disposed Open Form 4 filing 0000899243-22-028178
2022-08-05 S, Open-market sale Cerevel Therapeutics Holdings, Inc.CERE 1,248,780, disposed Open Form 4 filing 0000899243-22-028178

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 42
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Ceesay Abraham, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001722140

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.